Abstract:In angiotensin II (Ang II)-dependent hypertension, Ang II activates angiotensin II type 1 receptors (AT1R) on renal vascular smooth muscle cells, leading to renal vasoconstriction with eventual glomerular and tubular injury and interstitial inflammation. While afferent arteriolar vasoconstriction is initiated by the increased intrarenal levels of Ang II activating AT1R, the progressive increases in arterial pressure stimulate the paracrine secretion of adenosine triphosphate (ATP), leading to the purinergic P2X receptor (P2XR)-mediated constriction of afferent arterioles. Thus, the afferent arteriolar tone is maintained by two powerful systems eliciting the co-existing activation of P2XR and AT1R. This raises the conundrum of how the AT1R and P2XR can both be responsible for most of the increased renal afferent vascular resistance existing in angiotensin-dependent hypertension. Its resolution implies that AT1R and P2XR share common receptor or post receptor signaling mechanisms which converge to maintain renal vasoconstriction in Ang II-dependent hypertension. In this review, we briefly discuss (1) the regulation of renal afferent arterioles in Ang II-dependent hypertension, (2) the interaction of AT1R and P2XR activation in regulating renal afferent arterioles in a setting of hypertension, (3) mechanisms regulating ATP release and effect of angiotensin II on ATP release, and (4) the possible intracellular pathways involved in AT1R and P2XR interactions. Emerging evidence supports the hypothesis that P2X1R, P2X7R, and AT1R actions converge at receptor or post-receptor signaling pathways but that P2XR exerts a dominant influence abrogating the actions of AT1R on renal afferent arterioles in Ang II-dependent hypertension. This finding raises clinical implications for the design of therapeutic interventions that will prevent the impairment of kidney function and subsequent tissue injury.

The Relationship of the Two Subtypes of Angioensin II Receptor

Angiotensin II type-2 receptor-specific effects on the cardiovascular system.

Structural Insights into Ligand Recognition and Activation of Angiotensin Receptors.

Advances in Research into Cardiovascular Effect of Angiotensin II Type 2 Receptor

Interaction of Angiotensin II AT1 Receptors with Purinergic P2X Receptors in Regulating Renal Afferent Arterioles in Angiotensin II-Dependent Hypertension

The angiotensin II type 2 receptor for pain control

Relationship Between Angiotensin Ⅱ Type 1 Receptor/Autoantibodies in Plasma and Blood Pressure

AT2 Receptor Signaling and Sympathetic Regulation

Effect of genetic factors on target organ damage in patients with essential hypertension

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy

Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.

Angiotensin At(1) Receptors in Paraventricular Nucleus Contribute to Sympathetic Activation and Enhanced Cardiac Sympathetic Afferent Reflex in Renovascular Hypertensive Rats

Regulation of angiotensin Ⅱ receptor subtypes during atrial fibrillation in humans and the effect of angiotensin-converting enzyme inhibitors

Enhanced Hemodynamic Responses to Angiotensin II in Diabetes Are Associated with Increased Expression and Activity of AT1 Receptors in the Afferent Arteriole

Metoprolol Restores Expression and Vasodilatation Function of AT2R in Spontaneously Hypertensive Rats

Role of Angiotensin AT1 and AT2 Receptors in Cardiac Hypertrophy and Cardiac Remodelling.

[The Effects of Endothelin Blockade on Renal Expression of Angiotensin II Type 1 Receptor in Diabetic Hypertensive Rats].

Advance of the Relationship Between the Angiotensin Ⅱ Receptor and Tumor Resistance

Abstract P102: Type I Diabetes Mellitus is More Sensitive to Ang II Due to Increased AT1 Receptor Expression in Afferent Arteriole

The Relationship of Left Ventricular Hypertrophy and Ang iotensin Ⅱ Receptor in Spontaneously Hypertensive Rats

Plasma Angiotensin Ⅱ Type 2 Receptor in Relevant to Blood Pressure and Inflammatory Factors